Bio-Connect

Search results: SARS-CoV-2

337 to 348 of 10.229 products
Sort by
Product group Antibodies
References
GeneTex
ApplicationsELISA
ReactivityVirus
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsELISA
ReactivityVirus
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsELISA
ReactivityVirus
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsELISA, Neutralisation/Blocking
ReactivityVirus
TargetS
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
ReactivityVirus
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsWestern Blot
ReactivityVirus
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsImmunoFluorescence, ELISA, ImmunoCytoChemistry, Neutralisation/Blocking
ReactivityVirus
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsImmunoFluorescence, ELISA, ImmunoCytoChemistry, Neutralisation/Blocking
ReactivityVirus
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
ReactivityVirus
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
ReactivityVirus
TargetORF1ab
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
ReactivityVirus
TargetORF1ab
  • SizePrice
A. Recovery assay was determined by spiking SARS-CoV-2 N protein at various levels throughout the assay range in the listed samples. B. To determine linearity, the listed samples were spiked with SARS-CoV-2 N protein and diluted with Assay Diluent in 1:2 and 1:4. The value was assessed by comparing it to undiluted samples.
Product group Assays
GeneTex
ReactivityVirus
  • SizePrice